Skip to main content

Advertisement

Table 2 Questionnaire survey depicting long-term outcomes in women undergoing local anaesthetic thermal balloon endometrial ablation (LA-Thermachoice) between 2001 and 2011

From: The effectiveness of outpatient Thermachoice endometrial balloon ablation: a long-term 11-year outcome study

Variable Varma et al. [9]
2001–2005 2001–2011
Up to 3-year f/up Up to 11-year f/up
Response rate n = 88 (86 %) n = 190 (78 %)a
Mean follow-up time, months 30 62
 Range 12–54 12–134
 SD 13 42
Periods at review
 Amenorrhoea 27 (29 %) 106 (56 %)b
 Lighter 51 (55 %) 75 (39 %)
 No change or worse 15 (16 %) 9 (5 %)
Length of bleeding at review, n = 188
 No bleeding   106 (56 %)
 <3 days   26 (14 %)
 3–5 days   27 (14 %)
 6–7 days   16 (9 %)
 8–10 days   6 (3 %)
 >10 days   7 (4 %)
Dysmenorrhoea at review
 Less pain or no pain 64 (69 %) 167 (86 %)
 No change 11 (12 %) 18 (9 %)
 Worsening 18 (19 %) 10 (5 %)
Benefit maintained over time, n = 185
 Yes   149 (81 %)
 No   36 (19 %)
Further treatment (repeat ablation, drugs, LNG-IUS or hysterectomy), n = 187
 No 83 (81 %) 166 (89 %)
 Yes 19 (19 %) 21 (11 %)
Reason for further treatment, n = 21
 Bleeding   6 (29 %)
 Pain   8 (38 %)
 Both   7 (33 %)
All types of further treatment
 No further treatment 74 (73 %) 156 (82 %)
 LNG-IUS 3 (3 %) 4 (2 %)
 Drugs (including HRT) 9 (9 %) 9 (5 %)
 Repeat endometrial ablation 2 (2 %) 1 (0 %)
 Hysterectomyc 14(14 %) 20 (11 %)
Satisfaction, n = 186
 Very satisfied or satisfied 78 (76 %) 161 (86 %)
 Dissatisfied 24 (24 %) 25 (14 %)
  1. LNG-IUS = levonorgestrel releasing intrauterine system
  2. aData not recorded in all cases; calculations were based on cases that were reported
  3. bTen (5 %) responders reported that they had undergone menopause since the LA-TBEA
  4. cHistology of the 16 hysterectomies reported adenomyosis, leiomyoma, both adenomyosis and leiomyoma, no histological pathology, and no data recorded in 6, 2, 3, 5, and 4 cases, respectively